Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
3.705 USD | +0.14% | +0.14% | +21.48% |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | 40.87M | Capitalization | 311M |
---|---|---|---|---|---|
Net income 2024 * | -231M | Net income 2025 * | -246M | EV / Sales 2024 * | - |
Net cash position 2024 * | 543M | Net cash position 2025 * | 448M | EV / Sales 2025 * | -3.35 x |
P/E ratio 2024 * |
-1.34
x | P/E ratio 2025 * |
-1.27
x | Employees | 75 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 90.54% |
Latest transcript on Atea Pharmaceuticals, Inc.
1 day | +0.14% | ||
1 week | +0.14% | ||
Current month | -8.29% | ||
1 month | -3.01% | ||
3 months | -1.72% | ||
6 months | +25.17% | ||
Current year | +21.48% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 68 | 12-11-30 | |
Andrea Corcoran
DFI | Director of Finance/CFO | 61 | 13-11-30 |
Maria Horga
CTO | Chief Tech/Sci/R&D Officer | 55 | 20-07-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Franklin Berger
BRD | Director/Board Member | 74 | 19-08-31 |
Barbara Duncan
BRD | Director/Board Member | 59 | 20-09-30 |
Chief Executive Officer | 68 | 12-11-30 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.04% | 0 M€ | 0.00% | - | |
0.03% | 0 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-25 | 3.7 | 0.00% | 64 259 |
24-04-24 | 3.7 | -0.80% | 196,517 |
24-04-23 | 3.73 | +1.63% | 180,547 |
24-04-22 | 3.67 | -1.34% | 345,154 |
24-04-19 | 3.72 | +0.54% | 217,749 |
Delayed Quote Nasdaq, April 25, 2024 at 12:56 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+21.48% | 311M | |
-2.05% | 104B | |
+1.92% | 97.42B | |
+0.79% | 22.2B | |
-17.71% | 21.23B | |
-11.11% | 18.33B | |
-42.83% | 16.35B | |
-15.77% | 15.06B | |
+3.95% | 13.98B | |
+35.04% | 11.66B |
- Stock Market
- Equities
- AVIR Stock